Ambroxol chaperones GCase; in a previous study of people with Parkinson's disease, the drug led to increased GCase levels. It ...

A cough medicine used for decades in Europe called Ambroxol has shown promise for treating dementia in people with ...

Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson ...

The overall market for frontotemporal dementia is expected to grow with the anticipated launch of emerging therapies, including Latozinemab, PBFT02, ...

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...

A landmark study by London researchers investigating the use of a cough medicine called Ambroxo to slow the progression of ...

A commonly sold cough syrup in Europe could potentially slow down progression of dementia in patients with Parkinson’s ...

New research reveals that sugar metabolism in brain cells may be a crucial defense against Alzheimer’s and related dementias.

Get Instant Summarized Text (Gist) Ambroxol, a cough medicine, was found to be safe, well-tolerated, and reached therapeutic brain levels in people with Parkinson’s disease dementia.

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also ...

Semaglutide is linked to a reduced risk for Alzheimer’s disease-related dementia in patients with diabetes vs other antidiabetic drugs, a new study suggests.

Remarkable new findings about the sugar stores in neurons have unlocked an entire new method of treating Alzheimer's disease ...